Isolated isochromosome 17q: A distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 445-454

  McClure, R F ^a   Dewald, G W ^b   Hoyer, J D ^a   Hanson, Curtis A ^a,b  

^a Dept of Lab Med and Pathology ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic myeloproliferative disorder; Isochromosome 17q; Myelodysplastic syndrome; Pseudo Pelger Huet neutrophils

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CYTOGENETICS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; ISOCHROMOSOME; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 17; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCHROMOSOMES; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS;

EID: 0032870994     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01537.x     Document Type: Article

References (45)

1. Becher, R., Carbonell, F. & Bartram, C.R. (1990) Isochromosome 17q in Ph-negative leukemia: a clinical, cytogenetic, and molecular study. Blood, 75, 1679-1683.
2. Biegel, J.A., Rorke, L.B., Packer, R.J., Sutton, L.N., Schut, L., Bonner, K. & Emanuel, B.S. (1989) Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes, Chromosomes and Cancer, 1, 139-147.
3. Bitter, M.A., LeBeau, M.M., Larson, R.A., Larson, R.A., Rosner, M.C., Colomb, H.M., Rowley, J.D. & Vardiman, J.W. (1984) A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with Inv(16)(p13q22). American Journal of Clinical Pathology, 81, 733-741.
4. Borgstrom, G.H., Vuopia, P. & de la Chapelle, A. (1982) Abnormalities of chromosome no. 17 in myeloproliferative disorders. Cancer Genetics and Cytogenetics, 5, 123-135.
5. Cesarman, E., Chadburn, A., Inghirami, G., Gaidano, G. & Knowles, D.M. (1992) Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood, 80, 3205-3216.
6. Champlin, R.E. (1985) Chronic myelogenous leukemia: recent advances. Blood, 65, 1039-1047.
7. Chang, F., Syrjanen, S. & Syrjanen, K. (1995) Implications of the p53 tumor-suppressor gene in clinical oncology. Journal of Clinical Oncology, 13, 1009-1022.
8. Dewald, G.W., Schad, C.R., Christensen, E.R., Tiede, A.L., Zinsmeister, A.R., Spurbeck, J.L., Thibodeau, S.N. & Jalal, S.M. (1993) The application of fluorescent in situ hybridization to detect Mber/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genetics and Cytogenetics, 71, 7-14.
9. Engel, E., McKee, L.C., Flexner, J.M. & McGee, B.J. (1975) 17 long arm isochromosome: a common anomaly in malignant blood disorders. Annals of Genetics, 18, 56-60.
10. Fugazza, G.B.R., Puppo, L. & Sessarego, M. (1996) Granulocytes with segmented nucleus retain normal chromosomes 17 in Philadelphia chromosome-positive chronic myeloid leukemia with i(17q) and pseudo-Pelger anomaly: a case report studied with fluorescence in situ hybridization. Cancer Genetics and Cytogenetics, 90, 166-170.
11. Gandini, D., Cuneo, A., Carli, M.G., Lanza, F., Castoldi, G.L. & delSenno, L. (1994) Total loss of p53 DNA sequences in acute myeloid leukemia. Leukemia Research, 18, 63-65.
12. Greenberg, P., Cox, C., LeBeau, M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
13. Group, T.M.C.S. (1988) Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genetics and Cytogenetics, 32, 1-10.
14. Jary, L., Mossafa, H., Fourcade, C., Genet, P., Pulik, M. & Flandrin, G. (1997) The 17p-syndrome: a distinct myelodysplastic syndrome entity? Leukemia and Lymphoma, 25, 163-168.
15. Kakati, S., Oshimura, M. & Sandberg, A.A. (1976) The chromosomes and causation of human cancer and leukemia. XIX. Common markers in various tumors. Cancer, 38, 770-777.
16. Kaneko, Y., Abe, R., Sampi, K. & Sakurai, M. (1982) An analysis of chromosome findings in non-Hodgkin's lymphomas. Cancer Genetics and Cytogenetics, 5, 107-121.
17. Kantarjian, H.M., Deisseroth, A., Kurzrock, R., Estrov, Z. & Talpaz, M. (1993) Chronic myelogenous leukemia: a concise update. Blood, 82, 691-703.
18. Lai, J.-L., Preudhomme, C., Zandecki, M., Flactif, M., Vanrumbeke, M., Lepelley, P., Wattel, E. & Fenaux, P. (1995) Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion: an entity characterized by specific dysgranulopoiesis and high incidence of P53 mutations. Leukemia, 9, 370-381.
19. Li, C.Y., Yam, L.T. & Sun, T. (1996) Modern Modalities for the Diagnosis of Hematologic Neoplasms. Igaku-Schoin, New York.
20. Mark, J. (1977) On the specificity of medium-sized isomarker chromosomes in non-Burkitt lymphomas. Acta Pathologica et Microbiologica Scandinavica, 85, 557-558.
21. Mitelman, F. (1988) Catalog of Chromosome Aberrations in Cancer, 3rd edn. Alan R. Liss, New York.
22. Mitelman, F., Brandt, L. & Levan, G. (1973) Identification of isochromosome 17 in acute myeloid leukaemia. Lancet, i, 972.
23. Nakai, H., Misawa, S., Horiike, S., Maekawa, T., Kashima, K. & Ishizaki, K. (1995) Hemizygous expression of the wild-type p53 allele may confer a selective growth advantage before complete inactivation of the p53 gene in the progression of chronic myelogenous leukaemia. British Journal of Haematology, 90, 147-155.
24. Nakai, H., Misawa, S., Toguchida, J., Yandell, D.W. & Ishizaki, K. (1992) Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Research, 52, 6588-6593.
25. Neuwirtova, R., Mocikova, K., Musilova, J., Jelinek, J., Havlicek, F., Michalova, K. & Adamkov, M. (1996) Mixed myelodysplastic and myeloproliferative syndromes. Leukemia Research, 20, 717-726.
26. Nowell, P.C. & Finan, J.B. (1977) Isochromosome 17 in atypical myeloproliferative and lymphoproliferative disorders. Journal of the National Cancer Institute, 59, 329-331.
27. Oscier, D.G. (1996) Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? British Journal of Haematology, 92, 582-586.
28. Oshimura, M. & Sandberg, A.A. (1975) Isochromosome 17 in prostate cancer. Journal of Urology, 114, 249-250.
29. Pagliuca, A., Layton, D.M., Manoharan, A., Gordon, S., Green, P.J. & Mufti, G.J. (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. British Journal of Haematology, 71, 449-504.
30. Pasquali, F., Panarello, C., Bernasconi, P. & Casalone, R. (1982) The isochromosome (17q) in chronic myelocytic leukaemia: mechanism of origin, centomeric function and clonal evolution. Human Genetics, 62, 89-90.
31. Pedersen, B. & Kerndrup, G. (1990) Granulocyte maturation and the chromosome deletion 17p-in primary myelodysplastic syndrome. Acta Haematologica, 84, 77-81.
32. Rowley, J.D. (1990) Recurring chromosome abnormalities in leukemia and lymphoma. Seminars in Hematology, 27, 122-136.
33. Saxena, A., Clark, W.C., Robertson, J.T., Ikejiri, B., Oldfield, E.H. & Ali, I.U. (1992) Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Research, 52, 6716-6721.
34. Schutte, J., Opalka, B., Becher, R., Bardenheuer, W., Szymanski, S., Lux, A. & Seeber, S. (1993) Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or-negative myeloid leukemia. Leukemia Research, 17, 533-539.
35. Sessarego, M. & Ajmar, F. (1987) Correlation between acquired pseudo-Pelger-Huet anomaly and involvement of chromosome 17 in chronic myeloid leukemia. Cancer Genetics and Cytogenetics, 25, 265-270.
36. Shepherd, P.C.A., Ganesan, T.S. & Galton, D.A.G. (1987) Haematological classification of the chronic myeloid leukaemias. Bailliere's Clinical Haematology, 1, 887-906.
37. Shi, G., Weh, H.J. & Hossfeld, D.K. (1994) Demonstration of i(17q) in metaphase and interphase of malignant hematopoietic cells by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics, 73, 17-22.
38. Sieff, C.A., Chessells, J.M., Harvey, B.A.M., Pickhall, V.J. & Lawler, S.D. (1981) Monosomy 7 in childhood: a myeloproliferative disorder. British Journal of Haematology, 49, 235-249.
39. Singh, M., Bonfinger, K., Taylor., K. & BaPe, R. (1994) Myelodysplasia with myelofibrosis: a distinct subgroup within the myelodysplastic syndromes. Pathology, 26, 69-71.
40. Sokel, G., Michaux, J.L., Van Der Bergle, H., Cardier, A., Rodhain, J., Ferrant, A., Moriau, M., De Bruyere, M. & Sonnet, J. (1975) A new hematologic syndrome with a distinct karyotype: the 5q-chromosome. Blood, 46, 519-533.
41. Sole, F., Torrabadella, M., Granada, I., Florensa, L., Vallespi, T., Ribera, J.M., Irriguible, D., Milla, F. & Woessner, S. (1993) Isochromosome 17q as a sole anomoly: a distinct myelodysplastic syndrome entity? Leukemia Research, 17, 717-720.
42. Sultan, C., Sigaux, F., Imbert, M. & Reyes, F. (1981) Acute myelodysplasia with myelofibrosis: a report of eight cases. British Journal of Haematology, 49, 11-16.
43. Testa, J.R. & Cohen, B.C. (1986) Dicentric chromosome 17 in patients with leukemia. Cancer Genetics and Cytogenetics, 23, 47-52.
44. Weh, H.J., Kuse, R. & Hossfeld, D.K. (1990) Acute nonlymphocytic leukemia (ANLL) with isochromosome i(17q) as the sole chromosomal anomaly: a distinct entity? European Journal of Haematology, 44, 312-314.
45. White, G.R., Stack, M., Santibanez-Koref, M., Liscia, D.S., Venesio, T., Wang, J.C., Helms, C., Donis-Keller, H., Betticher, D.C., Altermatt, H.J., Hoban, P.R. & Heighway, J. (1996) High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor. British Journal of Cancer, 74, 863-870.